Ignite Creation Date:
2025-12-24 @ 2:23 PM
Ignite Modification Date:
2026-01-02 @ 11:29 AM
Study NCT ID:
NCT04440059
Status:
COMPLETED
Last Update Posted:
2024-04-18
First Post:
2020-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia
Sponsor:
Beijing InnoCare Pharma Tech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-09
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-16
First Submit QC Date:
None
Study First Post Date:
2020-06-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-17
Last Update Post Date:
2024-04-18
Last Update Post Date Type:
ACTUAL